Obstructive uropathy is interference and hindrance in the urinal tract causing barriers for the normal flow of urine completely or partially. Obstructive uropathy can be a result of structural or functional malfunction blocking the drainage of urine and can cause serious complications if not treated. Obstructive uropathy can be an acute or chronic disease. Obstructive uropathy treatment is applicable to people of all age groups as it may occur to individual of any age. Obstructive uropathy registers for 10% of the causes of acute renal failure and 4% of the cases of chronic end stage renal failure. Obstructive uropathy can be caused due to neoplastic, inflammation or may be inherited. Obstructive uropathy treatment involves introduction of catheters or stents in kidney or ureter to restore the normal flow of urine. Obstructive uropathy treatment is performed by minimal invasion and has significantly high success rate. Nephro-ureterostomy catheter passes through the skin and allows the flow of urine from bladder to the renal pelvis. Ureteral stent is implanted in the ureter and acts as tube to allow flow of urine from kidney to bladder. Hydro nephrosis is the condition in which there is excess fluid present in the kidney which is cured by obstructive uropathy treatment. Prompt relief of obstruction by obstructive uropathy treatment market usually leads to preservation of kidney function.
Obstructive Uropathy Treatment Market: Drivers and Restraints
The increasing prevalence of kidney stone due to changing lifestyle is the key factor propelling the expansion of global obstructive uropathy treatment market. Furthermore, increasing incidence of cancer and post-operative infection in kidney transplant patients fuel the expansion of obstructive uropathy treatment market. The rising prevalence of hydro nephrosis in the population is also expected to create a high demand for obstructive uropathy treatment over the forecast period. The rising number of manufacturers and distributors of catheters and stents for obstructive uropathy treatment are increasing the regional availability of the products in untapped regions and fueling the expansion of the obstructive uropathy treatment market. The increasing progress in research and development and improvement in patient outcomes is expected to create further opportunities in the obstructive uropathy treatment market over the forecast period.
Obstructive Uropathy Treatment Market: Overview
The global obstructive uropathy treatment market is expected to witness significant growth over the forecast period owing to the increasing adoption of the products by the end users. From an autopsy series of 59,064 subjects ranging in age from infants to geriatric people, it was reported that 3.1% were positive for hydro nephrosis and this number is further anticipated to rise propelling demand for obstructive Uropathy market. On the basis of product type, the ureteral stent segment is projected to register maximum market share in the terms of revenue over the forecast period owing to the better patient outcomes and availability of specific product types according to the requirements in the obstructive uropathy treatment market. The ambulatory surgical centres segment in end users is expected to grow with the fastest CAGR in the obstructive uropathy treatment market owing to the increasing number of outpatient centers.
Obstructive Uropathy Treatment Market: Regional Wise Outlook
Geographically, global obstructive uropathy treatment market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East & Africa (MEA). North America is expected to be the leader in global obstructive uropathy treatment market owing to the high prevalence of urological disorders in the region and higher expenditure of healthcare. Europe obstructive uropathy treatment market is projected to account for the second largest share in the obstructive uropathy treatment market over the forecast period due to higher spending on healthcare and greater adoption by the end users in the region. Asia-Pacific excluding Japan market for obstructive uropathy treatment is expected to grow with fast CAGR over the forecast period owing to the rising presence of manufacturers and increasing adoption by the end users. MEA obstructive uropathy treatment market is expected to witness below average growth due to lack of awareness and limited players in the region.
Obstructive Uropathy Treatment Market: Key Players
Some of the major players identified in the global obstructive uropathy treatment market are Boston Scientific Corporation, Olympus Corporation, Teleflex Incorporated, B. Braun Melsungen AG, Applied Medical, AngioDynamics, Merit Medical Systems, Inc., Argon Medical Devices, Inc., optimed, Cook Medical, and C. R. Bard amongst others.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The report covers exhaustive analysis on:
- Obstructive Uropathy Treatment Market Segments
- Obstructive Uropathy Treatment Market Dynamics
- Obstructive Uropathy Treatment Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Mexico, Brazil)
- Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
- Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
- Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
- Middle East and Africa (GCC, S. Africa, Rest Of MEA)
Obstructive Uropathy Treatment Market: Segmentation
Tentatively, the global obstructive uropathy treatment Market has been segmented on the basis of product type, end user, and geography.
Based on product type, global obstructive uropathy treatment market is divided into following:
- Nephro-ureterostomy catheter
- Ureteral Stents
- Open end stents
- Closed end stents
- Double pigtail stents
- Multi-loop stents
Based on end users, global obstructive uropathy treatment market is divided into following:
- Ambulatory Surgical Centers
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.